1. Home
  2. CTRM vs ADAP Comparison

CTRM vs ADAP Comparison

Compare CTRM & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRM
  • ADAP
  • Stock Information
  • Founded
  • CTRM 2016
  • ADAP 2008
  • Country
  • CTRM Cyprus
  • ADAP United Kingdom
  • Employees
  • CTRM N/A
  • ADAP N/A
  • Industry
  • CTRM Marine Transportation
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRM Consumer Discretionary
  • ADAP Health Care
  • Exchange
  • CTRM Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • CTRM 21.2M
  • ADAP 21.3M
  • IPO Year
  • CTRM N/A
  • ADAP 2015
  • Fundamental
  • Price
  • CTRM $1.97
  • ADAP $0.04
  • Analyst Decision
  • CTRM
  • ADAP Hold
  • Analyst Count
  • CTRM 0
  • ADAP 6
  • Target Price
  • CTRM N/A
  • ADAP $1.02
  • AVG Volume (30 Days)
  • CTRM 31.4K
  • ADAP 61.2M
  • Earning Date
  • CTRM 11-06-2025
  • ADAP 08-13-2025
  • Dividend Yield
  • CTRM N/A
  • ADAP N/A
  • EPS Growth
  • CTRM N/A
  • ADAP N/A
  • EPS
  • CTRM N/A
  • ADAP N/A
  • Revenue
  • CTRM $66,197,291.00
  • ADAP $65,084,999.00
  • Revenue This Year
  • CTRM N/A
  • ADAP N/A
  • Revenue Next Year
  • CTRM N/A
  • ADAP $52.35
  • P/E Ratio
  • CTRM N/A
  • ADAP N/A
  • Revenue Growth
  • CTRM N/A
  • ADAP N/A
  • 52 Week Low
  • CTRM $1.95
  • ADAP $0.04
  • 52 Week High
  • CTRM $4.64
  • ADAP $1.19
  • Technical
  • Relative Strength Index (RSI)
  • CTRM 30.76
  • ADAP 28.72
  • Support Level
  • CTRM $2.02
  • ADAP $0.06
  • Resistance Level
  • CTRM $2.10
  • ADAP $0.07
  • Average True Range (ATR)
  • CTRM 0.07
  • ADAP 0.01
  • MACD
  • CTRM -0.01
  • ADAP 0.00
  • Stochastic Oscillator
  • CTRM 6.67
  • ADAP 1.47

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

Share on Social Networks: